Spinal Muscular Atrophy (SMA): Historical Discovery
The clinical entity of spinal muscular atrophy was first described in the late 19th century. Key figures:
- Guido Werdnig (1891) and Johann Hoffmann (1893) independently reported severe infantile forms (now SMA type 1).
- Kugelberg and Welander (1956) described the milder juvenile/adult form (SMA type 3).
- Genetic basis: In 1995, the SMN1 gene on 5q13 was identified as the disease gene by Lefebvre et al. (Melki, Burghes groups).
Modern classification (types 0–4) based on age of onset and motor milestones. Disease-modifying therapies (nusinersen, onasemnogene abeparvovec, risdiplam) now target SMN protein restoration.
Bones, Joints & Muscles - Related Articles
- Understanding Joint Inflammation: Causes, Symptoms & Treatment
- Find a Hammertoes Specialist in Denver | Foot & Ankle Care
- Axial vs. Appendicular Skeleton: Complete Bone Classification
- Total Knee Replacement: Understanding Potential Side Effects & Recovery
- Understanding Diarthrodial Joints: Types & Function
- Knee Pain Relief: Effective Treatments & Recovery
- Mineralized Connective Tissue: Why Bone Is Hard
